Background: The prevalence of persistent lipid abnormalities in patients receiving statins in primary and secondary care is needed to formulate recommendations for future treatment. Studies associating cardiovascular risk factors with lipid target goal achievement are lacking. Design: A cross-sectional, observational study that assessed the prevalence of persistent dyslipidemia in patients treated with statins and analyzed predictors of lipid target achievement. Methods: Serum lipid values of 22,063 statin-treated patients were studied in the context of their cardiovascular risk factors, and the potency and composition of their lipid-lowering treatment. European Society of Cardiology recommendations were used to classify patient risk, and t...
Previous studies focused on attaining low-density lipoprotein cholesterol (LDL-C) goals after lipid-...
International audienceBACKGROUND: Few studies have been conducted in actual clinical practice settin...
AIMS Statins decrease the risk of fatal CVD by lowering low-density lipoprotein (LDL) lev...
Many statin-treated patients are not achieving treatment goals and are at risk of cardiovascular (CV...
A substantial number of cardiovascular events are not prevented by statin therapy, which is still re...
SummaryBackgroundResidual dyslipidaemia in patients treated with statins needs to be addressed to re...
Background: Data on the prevalence of dyslipidemia and attainment of goal/normal lipid levels in a S...
Aim To determine the prevalence and types of persistent dyslipidemia in patients treated with differ...
Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins h...
The high prevalence of persistent dyslipidemia in primary and specialised care patients treated with...
AIMS: Statins decrease the risk of fatal CVD by lowering low-density lipoprotein (LDL) levels. Guide...
PRINCIPLES: Statin therapy reduces cardiovascular morbidity and mortality. However, a substantial...
AbstractIntroductionThe purposes of this study are the characterization the lipid profile and the su...
BACKGROUND: patients with coronary heart disease (chd) and survivors of acute coronary syndrome (acs...
Introduction The purposes of this study are the characterization the lipid profile and the suitabil...
Previous studies focused on attaining low-density lipoprotein cholesterol (LDL-C) goals after lipid-...
International audienceBACKGROUND: Few studies have been conducted in actual clinical practice settin...
AIMS Statins decrease the risk of fatal CVD by lowering low-density lipoprotein (LDL) lev...
Many statin-treated patients are not achieving treatment goals and are at risk of cardiovascular (CV...
A substantial number of cardiovascular events are not prevented by statin therapy, which is still re...
SummaryBackgroundResidual dyslipidaemia in patients treated with statins needs to be addressed to re...
Background: Data on the prevalence of dyslipidemia and attainment of goal/normal lipid levels in a S...
Aim To determine the prevalence and types of persistent dyslipidemia in patients treated with differ...
Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins h...
The high prevalence of persistent dyslipidemia in primary and specialised care patients treated with...
AIMS: Statins decrease the risk of fatal CVD by lowering low-density lipoprotein (LDL) levels. Guide...
PRINCIPLES: Statin therapy reduces cardiovascular morbidity and mortality. However, a substantial...
AbstractIntroductionThe purposes of this study are the characterization the lipid profile and the su...
BACKGROUND: patients with coronary heart disease (chd) and survivors of acute coronary syndrome (acs...
Introduction The purposes of this study are the characterization the lipid profile and the suitabil...
Previous studies focused on attaining low-density lipoprotein cholesterol (LDL-C) goals after lipid-...
International audienceBACKGROUND: Few studies have been conducted in actual clinical practice settin...
AIMS Statins decrease the risk of fatal CVD by lowering low-density lipoprotein (LDL) lev...